Browse every startup, VC firm, and investor tracked on DevCuration. 6,061 companies, sorted alphabetically.
Self-learning AI agents that build a world model of enterprise workflows and improve via reps for higher reliability; 15-person team mostly PhDs from Ohio State research
Molecular glue degrader platform extending undruggable target universe; lead NEO-811 dosed first patient Feb 2026 for clear cell renal cell carcinoma; partners Novo, Biogen, AbbVie
Serverless Postgres with branching
Expanding DTC commerce infrastructure for game publishers
AI-bio precision medicine platform for cardio kidney metabolic disease; My Reason dataset of 42K+ consented patients with whole genome sequencing
Wirelessly powered peripheral nerve stimulation system for chronic pain integrating sensing with adaptive stimulation; UCLA-rooted clinical-stage medtech
Montreal-based mortgage technology and financing platform
AI-driven customer experience infrastructure (Autopilot, Co-Pilot, Agentic Insights) for enterprise CX in airlines, insurance, and financial services
Building network automation for AI infrastructure operators
Connecting academic biobanks and training disease-specific AI on patient tissue, blood, molecular, and clinical data.
Agentic SRE systems (Hawkeye, Falcon) for autonomous incident response; 230K+ alerts handled in 2025, $1.8M saved engineering spend, up to 90% MTTR reduction
AI security company that helps enterprises monitor, govern, and secure AI agents operating across business environments.
At-home physician-directed neuromodulation for Major Depressive Disorder (Proliv Rx); FDA Premarket Approval; partnered with BrainsWay
AI infrastructure company building an automated token engineering platform for enterprise AI workloads.
AI CoWorkers for preconstruction with proprietary skills graph orchestrating decisions; founders ex-Microsoft Azure and Alphabet
Developing soft, stretchable brain-computer interfaces for neurological applications.
One of the world's largest and most established venture capital firms, investing across technology and healthcare.
Developing epigenetic reprogramming medicines designed to restore youthful cellular function and address aging-related diseases.
CAR-T outpatient delivery centers: AI patient selection, remote monitoring, standardized clinical protocols, automated care coordination; partners with health systems to expand access beyond the ~150-200 hospitals currently administering CAR-T
Ambulatory care SaaS platform: EHR, practice management, RCM, interoperability, behavioral health, ambient documentation; 10K+ medical groups, 75K locations, 31M patients
Switching platforms and networking systems for hyperscale and NeoCloud AI clusters; integrates SONiC and FBOSS with merchant switching hardware; cumulative $610M; teams in Santa Clara, Seattle, Vancouver, Bengaluru
Global asset manager and flagship of SVCV multi-national group with strategies across private credit (NextShark), IP/music/film (NextGen), VC (DotCom); $5B target across funds; debut Next Gen Leaders fund; 100 acquisition targets including SVC Global, BT Global, TheGoPaPa Company